Clinical Study

Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Table 2

Nerve conduction studies. Values of different nerve parameters are reported before and after treatment in all groups.

PLACEBO EZE/SIMV ROSUV
BaselineFinalBaselineFinalBaselineFinal

Lower limbs
 Sural nerve
  Lat (ms)4.0 ± 0.53.6 ± 0.20.0064.1 ± 0.43.7 ± 0.10.0214.1 ± 0.63.8 ± 0.20.070
  Amp (µV)10.9 ± 12.015.9 ± 2.80.0849.5 ± 3.214.8 ± 2.90.47712.6 ± 6.615.2 ± 2.30.538
 Peroneal nerve
  Lat (ms)3.8 ± 0.83.7 ± 0.20.2073.7 ± 0.53.6 ± 0.20.2103.6 ± 0.93.5 ± 0.10.810
  Amp (mV)4.7 ± 3.15.0 ± 0.50.1914.5 ± 1.74.4 ± 0.40.8354.7 ± 2.64.5 ± 0.50.296
  Vel (m/s)39.3 ± 4.440.6 ± 1.10.00440.6 ± 3.841.5 ± 0.90.11139.9 ± 4.140.0 ± 0.80.944
 Tibiae nerve
  Lat (ms)4.2 ± 1.34.1 ± 0.20.3954.4 ± 0.94.5 ± 0.30.5624.3 ± 1.14.3 ± 0.20.776
  Amp (mV)8.4 ± 4.39.1 ± 1.20.0708.3 ± 3.37.9 ± 0.70.3908.2 ± 3.28.3 ± 0.90.972
  Vel (m/s)42.1 ± 5.443.1 ± 1.30.00844.2 ± 5.245.0 ± 0.90.05745.2 ± 6.344.4 ± 1.30.136
Upper limbs
 Median motor nerve
  Lat (ms)4.6 ± 1.45.5 ± 0.50.6556.5 ± 1.85.6 ± 1.00.6554.4 ± 0.85.0 ± 0.10.317
  Amp (mV)6.0 ± 1.34.5 ± 0.90.1806.5 ± 1.08.0 ± 0.80.6559.2 ± 3.97.3 ± 1.40.180
  Vel (m/s)47.4 ± 5.945.7 ± 3.80.18049.7 ± 3.851.2 ± 2.31.00041.7 ± 3.551.3 ± 4.90.317
 Median sensitive nerve
  Lat (ms)3.8 ± 0.63.7 ± 0.10.1413.9 ± 0.64.3 ± 0.20.0764.3 ± 0.74.2 ± 0.2 0.539
  Amp (µV)26.0 ± 14.526.4 ± 4.00.55322.2 ± 14.018.3 ± 2.40.47615.8 ± 6.421.6 ± 2.50.266
  Vel (m/s)52.2 ± 6.053.1 ± 1.30.19551.1 ± 5.252.8 ± 1.30.08352.8 ± 5.252.8 ± 1.50.778
 Ulnar motor nerve
  Lat (ms)3.5 ± 0.63.2 ± 0.10.0313.3 ± 0.33.4 ± 0.10.4793.4 ± 0.43.3 ± 0.10.468
  Amp (mV)8.3 ± 2.78.2 ± 0.70.8888.9 ± 2.78.0 ± 0.30.3388.3 ± 1.68.1 ± 0.40.394
  Vel (m/s)51.2 ± 8.551.6 ± 2.00.77655.0 ± 4.853.7 ± 1.30.19854.0 ± 4.453.9 ± 1.10.649
 Ulnar sensitive nerve
  Lat (ms)3.8 ± 0.83.6 ± 0.10.6293.7 ± 0.43.8 ± 0.10.6733.7 ± 0.73.7 ± 0.10.175
  Amp (µV)21.2 ± 23.921.5 ± 2.90.12719.8 ± 12.619.5 ± 3.10.93616.9 ± 7.717.8 ± 2.20.913
  Vel (m/s)53.7 ± 4.553.5 ± 1.50.46355.5 ± 5.755.1 ± 1.20.38054.3 ± 5.754.3 ± 1.10.448

Mean ± SEM, , versus placebo Mann-Whitney’s .